---
title: "BIO.B.US (BIO.B.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BIO.B.US/news.md"
symbol: "BIO.B.US"
name: "BIO.B.US"
parent: "https://longbridge.com/en/quote/BIO.B.US.md"
datetime: "2026-05-20T23:07:42.181Z"
locales:
  - [en](https://longbridge.com/en/quote/BIO.B.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BIO.B.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BIO.B.US/news.md)
---

# BIO.B.US (BIO.B.US) — Related News

### [Elliott significantly increased its position in Bio-Rad, driving its stock price to surge 13% in pre-market trading](https://longbridge.com/en/news/286770379.md)
*2026-05-18T12:22:18.000Z*
> Shares of life sciences and clinical diagnostics equipment supplier Bio-Rad Laboratories jumped 13% in pre-market tradin

### [Dow Jones Top Company Headlines at 9 PM ET: Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad | Rival ...](https://longbridge.com/en/news/286694585.md)
*2026-05-18T01:25:27.000Z*
> Elliott Management has acquired a significant stake in Bio-Rad, a life-science tools supplier. Budget airlines are takin

### [](https://longbridge.com/en/news/286688147.md)
*2026-05-18T00:06:45.000Z*
> Elliott increased its stake in life science tools supplier BIO-RAD

### [Bio-Rad Laboratories (NYSE:BIO.B) Sees Strong Trading Volume  - Should You Buy?](https://longbridge.com/en/news/285750935.md)
*2026-05-08T15:51:20.000Z*
> Bio-Rad Laboratories (NYSE:BIO.B) experienced a 27% increase in trading volume, with 380 shares traded on Friday. The st

### [Bio-Rad to Participate in Upcoming Investor Conferences | BIO Stock News](https://longbridge.com/en/news/285732039.md)
*2026-05-08T05:00:00.000Z*
> Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) announced its participation in two upcoming investor conferences. The f

### [Bio-Rad Laboratories (NYSE:BIO.B) Posts Earnings Results](https://longbridge.com/en/news/284839981.md)
*2026-04-30T21:28:05.000Z*
> Bio-Rad Laboratories (NYSE:BIO.B) reported quarterly earnings of $1.89 per share, with a net margin of 29.42% and a retu